Edgewise Therapeutics, Inc. EWTX Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s change in accrued liabilities?
- Edgewise Therapeutics, Inc. (EWTX) reported change in accrued liabilities of -$6.75M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s change in accrued liabilities changed year-over-year?
- Edgewise Therapeutics, Inc.'s change in accrued liabilities decreased by 11.0% year-over-year, from -$6.08M to -$6.75M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s change in accrued liabilities?
- Over 2 years (2021 to 2024), Edgewise Therapeutics, Inc.'s change in accrued liabilities has grown at a 64.0% compound annual growth rate (CAGR), from $1.62M to $4.36M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.